PMS Registry
In order to understand if there is other unknown side effect during the clinical trail, the PMS (Post-Marketing Study) will be conducted to learn more treatment experiences on patients, and collect their information for further study.
No. 9 of IRPMA COP Benchmarks regulates that all PMS shall go through JIRB, IRB or Ethics Committee and must be registered on the website of IRPMA PMS registry system. It is to ensure the studies conducted on patients have been approved by JIRB, IRB and protect patient’s right of privacy. The public can also get the information and objective of the PMS through the registry system.
Company Name
Title of Study
Update Date
Boehringer Ingelheim Taiwan Non-Interventional study (NIS) Collecting Experiences For IPF in Taiwan 2018-10-30
Boehringer Ingelheim Taiwan Patients’ Assessment of Satisfaction for Stroke Prevention in Atrial FibrillationImpact of Conventional Oral Anticoagulant (OAC) Compared with Novel Oral Anticoagulant (NOAC) 2018-10-22
Takeda Taiwan Safety and Effectiveness of Vedolizumab IV in Real World Clinical Practice in Taiwan: A Registry-Based Study 2018-10-22
Bayer XAMINA / Xarelto® on prevention of stroke and non-central nervous system systeMIc embolism in treatment Naïve Asian patients with non-valvular atrial fibrillation. 2018-09-05
Astellas Pharma Taiwan, Inc. A Phase IV Interventional Safety Study of ELIGARD® in Prostate Cancer Patients in Asia (ELIGANT) 2018-09-18
AbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan 2018-09-18
Astellas Pharma Taiwan, Inc. Non-interventional Study on the Safety and Efficacy of Micafungin for Prevention and Treatment of Fungal Infections in Pediatric Patients in Asia/Oceania – ERADICATE Study 2018-09-18
Daiichi Sankyo Taiwan Non-interventional study on edoxaban treatment in routine clinical practice for patients with non valvular atrial fibrillation in Korea and Taiwan 2018-09-18
Daiichi Sankyo Taiwan Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice in Patients with Venous Thromboembolism in Korea and Taiwan 2018-09-18
Pfizer Inc. Health-related quality life and health utility among Taiwanese women with advanced/metastatic breast cancer 2018-09-18
   1 2 3 4 5